Research article
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
-
* Corresponding author: Konstantinos T Papazisis kpapazisis@the.forthnet.gr
1 3rd Department of Medical Oncology, Theagenion Cancer Hospital, Al Simeonidi str. 2, 54007, Thessaloniki, Greece
2 Applied Molecular Oncology Laboratory, Theagenion Cancer Hospital, Al Simeonidi str. 2, 54007, Thessaloniki, Greece
3 Laboratory of biochemistry, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece
BMC Cancer 2009, 9:82 doi:10.1186/1471-2407-9-82
Published: 12 March 2009Additional files
Additional file 1:
Mean plasma values of angiogenesis markers in patients that progressed (PD) or had a clinical benefit (CB) on evaluation after two cycles of treatment.
Format: DOC Size: 44KB Download file
This file can be viewed with: Microsoft Word Viewer
